Yayın:
Therapy of Metastasized Prostate Cancer Using a Lu-177 Labeled PSMA Inhibitor (I&T): First Dosimetric Results in Patients

Basit öğe sayfası
dc.contributor.authorSchuchardt, C.
dc.contributor.authorWiessalla, S.
dc.contributor.authorOzkan, A.
dc.contributor.authorKulkarni, H. R.
dc.contributor.authorShahinfar, M.
dc.contributor.authorSayeg, M.
dc.contributor.authorWeineisen, M.
dc.contributor.authorWester, H. J.
dc.contributor.authorBaum, R. P.
dc.date.accessioned2026-06-27T13:43:38Z
dc.date.issued2015
dc.identifier.eissn1619-7089
dc.identifier.endpageS99
dc.identifier.issn1619-7070
dc.identifier.startpageS99
dc.identifier.urihttps://hdl.handle.net/20.500.14981/54535
dc.identifier.volume42
dc.identifier.wos000363013201171
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.conference28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
dc.relation.ispartofEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
dc.subjectRadiology, Nuclear Medicine & Medical Imaging
dc.titleTherapy of Metastasized Prostate Cancer Using a Lu-177 Labeled PSMA Inhibitor (I&T): First Dosimetric Results in Patients
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar